rs1060501418

Variant summary

Our verdict is Pathogenic. The variant received 20 ACMG points: 20P and 0B. PVS1PS1_ModeratePM2PP5_Very_Strong

The NM_001114753.3(ENG):​c.1A>G​(p.Met1?) variant causes a start lost change. The variant allele was found at a frequency of 0.000000696 in 1,436,158 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 7.0e-7 ( 0 hom. )

Consequence

ENG
NM_001114753.3 start_lost

Scores

5
7
4

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:5

Conservation

PhyloP100: 3.63

Publications

11 publications found
Variant links:
Genes affected
ENG (HGNC:3349): (endoglin) This gene encodes a homodimeric transmembrane protein which is a major glycoprotein of the vascular endothelium. This protein is a component of the transforming growth factor beta receptor complex and it binds to the beta1 and beta3 peptides with high affinity. Mutations in this gene cause hereditary hemorrhagic telangiectasia, also known as Osler-Rendu-Weber syndrome 1, an autosomal dominant multisystemic vascular dysplasia. This gene may also be involved in preeclampsia and several types of cancer. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2013]
ENG Gene-Disease associations (from GenCC):
  • telangiectasia, hereditary hemorrhagic, type 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, ClinGen
  • hereditary hemorrhagic telangiectasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • juvenile polyposis syndrome
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 20 ACMG points.

PVS1
Start lost variant, next in-frame start position is after 123 pathogenic variants. Next in-frame start position is after 183 codons. Genomic position: 127825837. Lost 0.277 part of the original CDS.
PS1
Another start lost variant in NM_001114753.3 (ENG) was described as [Pathogenic] in ClinVar
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 9-127854355-T-C is Pathogenic according to our data. Variant chr9-127854355-T-C is described in ClinVar as Pathogenic. ClinVar VariationId is 407131.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ENGNM_001114753.3 linkc.1A>G p.Met1? start_lost Exon 1 of 15 ENST00000373203.9 NP_001108225.1 P17813-1Q96CG0A0A024R878
ENGNM_000118.4 linkc.1A>G p.Met1? start_lost Exon 1 of 14 NP_000109.1 P17813-2Q5T9B9
ENGNM_001406715.1 linkc.1A>G p.Met1? start_lost Exon 1 of 8 NP_001393644.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENGENST00000373203.9 linkc.1A>G p.Met1? start_lost Exon 1 of 15 1 NM_001114753.3 ENSP00000362299.4 P17813-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.96e-7
AC:
1
AN:
1436158
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
712250
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32864
American (AMR)
AF:
0.00
AC:
0
AN:
41018
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25612
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38132
South Asian (SAS)
AF:
0.00
AC:
0
AN:
82266
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51238
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5718
European-Non Finnish (NFE)
AF:
9.09e-7
AC:
1
AN:
1099984
Other (OTH)
AF:
0.00
AC:
0
AN:
59326
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Telangiectasia, hereditary hemorrhagic, type 1 Pathogenic:2
Sep 29, 2022
Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PVS1, PM2, PS4_moderate -

Jan 01, 2018
NIHR Bioresource Rare Diseases, University of Cambridge
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:research

PVS1+PM2+PP4 -

not specified Pathogenic:1
Apr 17, 2017
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Pathogenic:1
Jul 30, 2020
Ambry Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.M1? pathogenic mutation (also known as c.1A>G and p.M1V) is located in coding exon 1 of the ENG gene and results from an A to G substitution at nucleotide position 1. This alters the methionine residue at the initiation codon (ATG). This alteration has been identified in multiple individuals with hereditary hemorrhagic telangiectasia, most of whom meet Cura&ccedil;ao criteria (Letteboer TG et al. Hum Genet. 2005; 116(1-2):8-16; Lenato GM et al. Hum Mutat. 2006; 27(2):213-4; Gedge F et al. J Mol Diagn. 2007; 9(2):258-65; Curie A et al. J. Pediatr. 2007; 151(3):299-306; Calhoun AR et al. J Neurosurg Pediatr 2012; 9(6):654-9; Eli I et al. J Clin Neurosci 2018; 50:51-57; Gamboa NT et al. J Clin Neurosci 2018; 51:22-28). In addition to the clinical data presented in the literature, sequence variations that modify the initiation codon are expected to result in either loss of translation initiation, N-terminal truncation, or cause a shift in the mRNA reading frame. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -

Hereditary hemorrhagic telangiectasia Pathogenic:1
Aug 02, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 407131). Disruption of the initiator codon has been observed in individuals with hereditary haemorrhagic telangiectasia (PMID: 15517393, 16429404, 32573726; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change affects the initiator methionine of the ENG mRNA. The next in-frame methionine is located at codon 183. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.23
D
BayesDel_noAF
Uncertain
0.090
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Benign
0.38
T;.
Eigen
Uncertain
0.38
Eigen_PC
Uncertain
0.36
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Uncertain
0.90
D;D
M_CAP
Pathogenic
0.93
D
MetaRNN
Pathogenic
0.99
D;D
MetaSVM
Benign
-0.74
T
PhyloP100
3.6
PROVEAN
Benign
-1.7
N;N
REVEL
Uncertain
0.45
Sift
Pathogenic
0.0
D;D
Sift4G
Pathogenic
0.0
D;D
Polyphen
0.99
D;.
Vest4
0.96
MutPred
1.0
Loss of stability (P = 0.0961);Loss of stability (P = 0.0961);
MVP
0.92
ClinPred
1.0
D
GERP RS
5.6
PromoterAI
-0.15
Neutral
Varity_R
0.90
gMVP
0.83
Mutation Taster
=3/197
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1060501418; hg19: chr9-130616634; API